12-month real-world achievements for Diabeloop's AID
21. September 2022 02:00 ET
|
Diabeloop SA
PARIS, Sept. 21, 2022 (GLOBE NEWSWIRE) -- EASD 2022 - Diabeloop, a leader in therapeutic AI applied to insulin delivery, reports today on 12 months of use of its hybrid closed-loop DBLG1 System on a...
Diabeloop Presents New Real-Life Results of DBLG1® System
28. April 2022 08:00 ET
|
Diabeloop SA
PARIS, April 28, 2022 (GLOBE NEWSWIRE) -- At ATTD 2022 - Diabeloop, a pioneer in therapeutic artificial intelligence for diabetes management, presents today new results from a real-life cohort in...